P48643 (TCPE_HUMAN) Homo sapiens (Human)
T-complex protein 1 subunit epsilon UniProtKBInterProSTRINGInteractive Modelling
Available Structures
53 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
CCT G beta 5 complex closed state 15 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 14 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 0 |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT-G beta 5 complex closed state 7 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex intermediate state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; | |||
CCT G beta 5 complex close state 11 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 12 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 2 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT-G beta 5 complex closed state 6 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 13 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT-G beta 5 complex closed state 4 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 9 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 1 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 10 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 3 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex best PhLP1 class |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT-G beta 5 complex closed state 8 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
CCT G beta 5 complex closed state 5 |
Heteromer O14775; P17987; P40227; P49368; P50990; P50991; P78371; Q13371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound |
Heteromer P17987; P40227; P49368; P50990; P50991; P63261; P78371; Q99832; Q9H2J4; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
Human TRiC complex in closed state with nanobody and tubulin bound |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q13885; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
cryo-EM structure of human TRiC-ADP-AlFx |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
Human TRiC-tubulin-S3 |
Heteromer P07437; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
cryo-EM structure of human TRiC-ATP-closed state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | ||||
Human TRiC complex in closed state with nanobody bound (Consensus Map) |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
The beta-tubulin folding intermediate IV |
Heteromer P07437; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 8×MG; 8×ADP; 8×AF3; | |||
The beta-tubulin folding intermediate II |
Heteromer P07437; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 8×AF3; 8×MG; 8×ADP; | |||
The beta-tubulin folding intermediate III |
Heteromer P07437; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 8×MG; 8×ADP; 8×AF3; | |||
Human TRiC/CCT complex with reovirus outer capsid protein sigma-3 |
Heteromer P03527; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 1×ZN; | |||
Human TRiC in ATP/AlFx closed state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | ||||
The beta-tubulin folding intermediate I |
Heteromer P07437; P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 8×MG; 8×ADP; 8×AF3; | |||
Human TRiC-PhLP2A-actin complex in the closed state |
Heteromer P17987; P40227; P49368; P50990; P50991; P60709; P78371; Q99832; Q9H2J4; | 100 | ||||
Human TRiC-PhLP2A complex in the closed state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; Q9H2J4; | 100 | 16×ADP; 16×MG; 16×AF3; | |||
Cryo-EM structure of Human TRiC-ATP-open state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | ||||
Cryo-EM structure of human TRiC-NPP state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | ||||
Human TRiC open state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100.0 | 6×ADP; | |||
Human CCT:mLST8 complex |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100.0 | 2×ADP; | |||
Cryo-EM structure of human TRiC-tubulin-S2 |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ATP; | |||
cryo-EM structure of human TRiC-ADP |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 16×ADP; | |||
Open state CCT-G beta 5 complex |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100.0 | 16×ADP; | |||
hTRiC-hPFD Class3 |
Heteromer O15212; O60925; P17987; P40227; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; | 100 | ||||
hTRiC-hPFD Class6 |
Heteromer O15212; O60925; P17987; P40227; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; | 100 | ||||
hTRiC-hPFD Class5 |
Heteromer O15212; O60925; P17987; P40227; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; | 100 | ||||
hTRiC-hPFD Class1 (No PFD) |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | ||||
hTRiC-hPFD Class4 |
Heteromer O15212; O60925; P17987; P40227; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; | 100 | ||||
hTRiC-hPFD Class2 |
Heteromer O15212; O60925; P17987; P40227; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; | 100 | ||||
Negative-stain electron microscopy structure of DDB1-DCAF12-CCT5 |
Heteromer Q16531; Q5T6F0; | 100 | ||||
Human TRiC-PhLP2A complex in the open state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; Q9H2J4; | 100 | 10×ADP; | |||
Cryo-EM structure of human TRiC-tubulin-S1 state |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100 | 6×ADP; | |||
Human TRiC complex in open state with nanobody bound |
Heteromer P17987; P40227; P49368; P50990; P50991; P78371; Q99832; | 100.0 | 16×MG; 16×ADP; 12×AF3; | |||
Prefoldin-tubulin-TRiC complex |
Heteromer O15212; O60925; P17987; P40227; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9; | 100 | 4×ADP; | |||
Structure of human DDB1-DCAF12 in complex with the C-terminus of CCT5 |
Heteromer Q16531; Q5T6F0; | 100 | ||||
Structure of Human T-complex protein 1 subunit epsilon (CCT5) mutant His147Arg | homo-16-mer | 99.8 | 16×ADP; 12×MG; | |||
Structure of Human T-complex protein 1 subunit epsilon (CCT5) | homo-16-mer | 100.0 | 16×ADP; | |||
2 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7nvm.1.D | monomer | 0.78 | 1×ADP; 1×AF3; | 100.00 | ||
5uyx.1.P | monomer | 0.69 | 1×ADP; | 100.00 | ||
2 SWISS-MODEL models built on isoform sequence
Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|---|
Isoform 2 | 6nra.1.M | monomer | 0.67 | 97.74 | |||
Isoform 2 | 8ba7.1.J | monomer | 0.56 | 18.53 | |||